Left ventricular (LV) wall thickening, or LV hypertrophy (LVH), is common and occurs in diverse conditions including hypertrophic cardiomyopathy (HCM), hypertensive heart disease, aortic valve stenosis, lysosomal storage disorders, cardiac amyloidosis, mitochondrial cardiomyopathy, sarcoidosis and athlete's heart. Cardiac magnetic resonance (CMR) imaging provides various tissue contrasts and characteristics that reflect histological changes in the myocardium, such as cellular hypertrophy, cardiomyocyte disarray, interstitial fibrosis, extracellular accumulation of insoluble proteins, intracellular accumulation of fat, and intracellular vacuolar changes. Therefore, CMR imaging may be beneficial in establishing a differential diagnosis of LVH...
BACKGROUND: Echocardiography- and cardiovascular magnetic resonance (CMR)-based studies have reveale...
Myocardial disarray is a likely focus for fatal ventricular arrhythmia in hypertrophic cardiomyopath...
Background: Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but s...
Abstract Objectives The purpose of this article is to describe the key cardiac magnetic resonance im...
Abstract Hypertrophic cardiomyopathy (HCM) is characterized by substantial genetic and phenotypic he...
ObjectivesThe purpose of this study was to evaluate whether structural left ventricular (LV) abnorma...
Cardiovascular disease contributes greatly to the disease burden in many developed countries. Cardi...
Purpose To evaluate myocardial strain and circumferential transmural strain difference (cTSD; the di...
Non-ischemic cardiomyopathies represent a heterogeneous group of myocardial diseases potentially lea...
Rapid advances in cardiac computed tomography (CT) have enabled the characterization of left ventric...
Multimodality imaging is indicated for the evaluation of left ventricular (LV) myocardial diseases. ...
The aim of this paper is to present recent advances in hypertrophic cardiomyopathy (HCM) diagnosis a...
ObjectivesEuropean guidelines state left ventricular (LV) end-diastolic wall thickness (EDWT) ≥15mm ...
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in clinical practic...
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1:5...
BACKGROUND: Echocardiography- and cardiovascular magnetic resonance (CMR)-based studies have reveale...
Myocardial disarray is a likely focus for fatal ventricular arrhythmia in hypertrophic cardiomyopath...
Background: Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but s...
Abstract Objectives The purpose of this article is to describe the key cardiac magnetic resonance im...
Abstract Hypertrophic cardiomyopathy (HCM) is characterized by substantial genetic and phenotypic he...
ObjectivesThe purpose of this study was to evaluate whether structural left ventricular (LV) abnorma...
Cardiovascular disease contributes greatly to the disease burden in many developed countries. Cardi...
Purpose To evaluate myocardial strain and circumferential transmural strain difference (cTSD; the di...
Non-ischemic cardiomyopathies represent a heterogeneous group of myocardial diseases potentially lea...
Rapid advances in cardiac computed tomography (CT) have enabled the characterization of left ventric...
Multimodality imaging is indicated for the evaluation of left ventricular (LV) myocardial diseases. ...
The aim of this paper is to present recent advances in hypertrophic cardiomyopathy (HCM) diagnosis a...
ObjectivesEuropean guidelines state left ventricular (LV) end-diastolic wall thickness (EDWT) ≥15mm ...
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in clinical practic...
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1:5...
BACKGROUND: Echocardiography- and cardiovascular magnetic resonance (CMR)-based studies have reveale...
Myocardial disarray is a likely focus for fatal ventricular arrhythmia in hypertrophic cardiomyopath...
Background: Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but s...